Abu Dhabi Stem Cells Center (ADSCC) has announced a partnership with Emirates Red Crescent (ERC) to expand access to bone marrow transplants for patients in need. The collaboration will provide medical consultations and support through ADSCC’s Abu Dhabi Bone Marrow Transplant (BMT) Programme. The aim is to offer critical treatments to individuals suffering from blood cancers, blood disorders, and autoimmune diseases like multiple sclerosis.
Under the agreement, ADSCC and ERC will also work together on fundraising initiatives to finance BMT procedures for underprivileged patients. The partnership reflects the shared commitment of both organizations to alleviate the suffering of patients and strengthen cooperation to achieve better health outcomes. Mohammed Al Fahim, Deputy Secretary General of Support Services Sector at ERC, praised the initiative, emphasizing the importance of strategic partnerships in healthcare.
Dr Maysoon Al Karam, Chief Medical Officer of ADSCC, highlighted the goal of bridging the gap in healthcare access and ensuring state-of-the-art treatments are available to those in need. ADSCC’s Abu Dhabi Bone Marrow Transplant Programme, accredited as a Centre of Excellence in Hematopoietic Stem Cell Transplantation, has been offering holistic care for autologous and allogeneic bone marrow transplants since 2020. By providing advanced treatments locally, the program eliminates the need for patients to seek medical care abroad, enhancing convenience for patients and their families while reducing healthcare expenditures.
Overall, this partnership between ADSCC and ERC signifies a significant step towards improving accessibility to bone marrow transplants and enhancing healthcare outcomes for patients suffering from critical diseases.
